Do elevations in ALT, AST, GGT and ferritin indicate metabolic liver stress?

Elevated liver enzymes and ferritin are frequently co-observed clinical markers that signify underlying metabolic dysfunction-associated steatotic liver disease (MASLD/NAFLD) and active hepatic necro-inflammation. This biochemically distinct pattern reflects systemic metabolic liver stress and a feed-forward loop of cellular injury.

Clinical and metabolic significance

• Biomarker Synergy: Alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (GGT) serve as classic markers of hepatocellular damage and biliary/oxidative stress.
• Hyperferritinemia Prevalence: Elevated serum ferritin occurs in approximately one-third of individuals with NAFLD. This elevation acts as a marker of chronic, low-grade systemic inflammation and metabolic syndrome rather than true genetic iron overload.

Mechanistic pathways of liver stress

• Cytokine-Driven Synthesis: Chronic hepatic inflammation stimulates the upregulation of ferritin synthesis via pro-inflammatory cytokines such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and IL-1β. Damaged, lipotoxic hepatocytes subsequently leak these intracellular proteins into circulation.
• Pathogenic Amplification: Extracellular ferritin is not merely a passive bystander; it acts as an active pro-inflammatory cytokine. It directly stimulates hepatic stellate cells, driving lipid peroxidation, oxidative stress, and fibrogenesis.
• Metabolic Entrapment: Insulin resistance alters iron homeostasis by upregulating hepcidin, which traps iron within Kupffer cells and hepatocytes, worsening oxidative stress and accelerating tissue remodeling.

Bottom line

• The combined elevation of ALT, AST, GGT, and ferritin reflects a state of active metabolic liver stress and chronic inflammation, where ferritin acts as both a sensitive inflammatory proxy and a direct pathogenic driver of progressive liver injury and fibrosis.